About-us technologies products Clinical-trials collaborations news careers contact-us
About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>

About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

Recent News

Zürich (Switzerland),
3rd March, 2015

Philochem announces the publication in the prestigious journal Nature Chemistry of an article entitled 'Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation'.
(see full press release)

Upcoming Events

Kobe (Japan),
27h March, 2015

Dario Neri will present "Antibody-cytokine fusion proteins: from the bench to the clinic" at 1st International Symposium for Medicinal Sciences organized by the Pharmaceutical Society of Japan (PSJ) in association with the 135th Annual Meeting of the PSJ (Kobe (JP), 25th-28th March, 2015).